UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

Breast cancer research and treatment, 2011-06, Vol.127 (2), p.429-438

2011

Volltextzugriff (PDF)

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring

British journal of cancer, 2009-03, Vol.100 (5), p.684-692

2009

Volltextzugriff (PDF)

Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk

Annals of oncology, 2009-05, Vol.20 (5), p.816-827

2009

Volltextzugriff (PDF)

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy

British journal of cancer, 2000-01, Vol.82 (1), p.93-97

2000

Volltextzugriff (PDF)

Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: a review of chemotherapy

Endocrine-related cancer, 2005-07, Vol.12 (Supplement_1), p.S125-S133

Barrett-Lee, P J

2005

Volltextzugriff (PDF)

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

The Lancet (British edition), 2014-06, Vol.383 (9935), p.2127-2135

2014

Volltextzugriff (PDF)

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

The lancet oncology, 2008-04, Vol.9 (4), p.331-341

2008

Volltextzugriff (PDF)

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials

The lancet oncology, 2010-03, Vol.11 (3), p.231-240

2010

Volltextzugriff (PDF)

Docetaxel in the community setting: An analysis of 377 breast cancer patients treated with docetaxel (Taxotere®) in the UK

Annals of oncology, 1999-02, Vol.10 (2), p.205-210

1999

Volltextzugriff (PDF)

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Radiotherapy and oncology, 2011-07, Vol.100 (1), p.93-100

2011

Volltextzugriff (PDF)

Trastuzumab in Patients on Haemodialysis for Renal Failure

Clinical oncology (Royal College of Radiologists (Great Britain)), 2007-09, Vol.19 (7), p.559-559

2007

Volltextzugriff (PDF)

Interim safety data on the ZICE trial: A randomized phase III, open-label, multicener, parallel group clinical trial to evaluate and compare the efficacy, safety profile, and tolerability of oral ibandronate versus intravenous zoledronate in the treatment of patients with breast cancer with bone metastases

Journal of clinical oncology, 2010, Vol.28 (15_suppl), p.1085-1085

2010

Volltextzugriff (PDF)

Growth factor expression in normal, benign, and malignant breast tissue

BMJ, 1988-06, Vol.296 (6637), p.1621-1624

1988

Volltextzugriff (PDF)

The Incidence and Treatment Outcome after Radiotherapy for Brain Metastases in HER-2-positive Metastatic Breast Cancer Patients Treated with Trastuzumab

Clinical oncology (Royal College of Radiologists (Great Britain)), 2006-11, Vol.18 (9), p.719-720

2006

Volltextzugriff (PDF)

Improvement in quality of life for cancer patients treated with epoetin alfa

European journal of cancer care, 2001-09, Vol.10 (3), p.183-191

2001

Volltextzugriff (PDF)

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

The Lancet (British edition), 2011-08, Vol.378 (9793), p.771-784

2011

Volltextzugriff (PDF)

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

The Lancet (British edition), 2008-03, Vol.371 (9618), p.1098-1107

2008

Volltextzugriff (PDF)

Characterization of estrogen receptor messenger RNA in human breast cancer

Cancer research (Chicago, Ill.), 1987-12, Vol.47 (24), p.6653-6659

1987

Volltextzugriff (PDF)

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Annals of oncology, 2003-09, Vol.14 (9), p.1399-1405

2003

Volltextzugriff (PDF)

Independent Risk Factors for Anemia in Cancer Patients Receiving Chemotherapy: Results from the European Cancer Anaemia Survey

Oncology, 2006-01, Vol.70 (1), p.34-48

2006

Volltextzugriff (PDF)

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE–BIG 01–04) for women with stage II/III breast cancer

Bone (New York, N.Y.), 2011-01, Vol.48 (1), p.S29-S29

2011

Volltextzugriff (PDF)

Prevalence of anemia in cancer patients not receiving antineoplastic treatment (ANT): Data from the European Cancer Anaemia Survey (ECAS)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.8565-8565

2006

Volltextzugriff (PDF)

Phase II data for entinostat, a class 1 selective histone deacetylase inhibitor, in patients whose breast cancer is progressing on aromatase inhibitor therapy

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1052-1052

2010

Volltextzugriff (PDF)

Abstract PD07-09: Zoledronate versus ibandronate comparative evaluation (ZICE) trial - first results of a UK NCRI 1,405 patient phase III trial comparing oral ibandronate versus intravenous zoledronate in the treatment of breast cancer patients with bone metastases

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.PD07-09-PD07-09

2012

Volltextzugriff (PDF)

Final results of NKTR-102, a topoisomerase I inhibitor-polymer conjugate, in patients (Pts) with pretreated metastatic breast cancer (MBC) demonstrating significant antitumor activity

Journal of clinical oncology, 2011-09, Vol.29 (27_suppl), p.269-269

2011

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Englisch
(123)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(64)
Science & Technology
(64)
Humans
(61)
Female
(53)
Oncology
(45)
Breast Neoplasms - Drug Therapy
(33)
Breast Cancer
(32)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Middle Aged
(29)
Tumors
(28)
Adult
(23)
Aged
(23)
Chemotherapy
(18)
Gynecology. Andrology. Obstetrics
(18)
Mammary Gland Diseases
(18)
Hematology, Oncology And Palliative Medicine
(17)
Breast Neoplasms - Pathology
(16)
Aged, 80 And Over
(14)
Breast Neoplasms - Surgery
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(20)
British Journal Of Cancer
(10)
Clinical Oncology
(10)
Journal Of Clinical Oncology
(10)
European Journal Of Cancer
(9)
Annals Of Oncology
(6)
European Journal Of Cancer Supplements
(6)
Lancet
(4)
The Lancet
(4)
Breast
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring

Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy

Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: a review of chemotherapy

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials

Docetaxel in the community setting: An analysis of 377 breast cancer patients treated with docetaxel (Taxotere®) in the UK

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Trastuzumab in Patients on Haemodialysis for Renal Failure

Growth factor expression in normal, benign, and malignant breast tissue

The Incidence and Treatment Outcome after Radiotherapy for Brain Metastases in HER-2-positive Metastatic Breast Cancer Patients Treated with Trastuzumab

Improvement in quality of life for cancer patients treated with epoetin alfa

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

Characterization of estrogen receptor messenger RNA in human breast cancer

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

Independent Risk Factors for Anemia in Cancer Patients Receiving Chemotherapy: Results from the European Cancer Anaemia Survey

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE–BIG 01–04) for women with stage II/III breast cancer

Prevalence of anemia in cancer patients not receiving antineoplastic treatment (ANT): Data from the European Cancer Anaemia Survey (ECAS)

Phase II data for entinostat, a class 1 selective histone deacetylase inhibitor, in patients whose breast cancer is progressing on aromatase inhibitor therapy

Abstract PD07-09: Zoledronate versus ibandronate comparative evaluation (ZICE) trial - first results of a UK NCRI 1,405 patient phase III trial comparing oral ibandronate versus intravenous zoledronate in the treatment of breast cancer patients with bone metastases

Final results of NKTR-102, a topoisomerase I inhibitor-polymer conjugate, in patients (Pts) with pretreated metastatic breast cancer (MBC) demonstrating significant antitumor activity

Suchergebnisse filtern